Predictive value of TP53 fluorescence in situ hybridization in cytogenetic subgroups of acute myeloid leukemia

Leukemia and Lymphoma

Volumn 52, Issue 4, 2011, Pages 642-647

  Tavor, Sigal ^a   Rothman, Rachel ^a   Golan, Tamar ^a   Voskoboinik, Nadia ^a   Katz, Ben Zion ^a,b   Sarid, Nadav ^a   Shomrat, Ruth ^a   Orr Urtreger, Avi ^a,b   Naparstek, Elizabeth ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

AML; FISH; karyotype; prognosis; TP53

Indexed keywords

CYTARABINE; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; MITOXANTRONE; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER REGRESSION; CHROMOSOME 12; CHROMOSOME 17P; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; KARYOTYPE; MONOSOMY; OVERALL SURVIVAL; PARTIAL MONOSOMY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 79953218064     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.551571     Document Type: Article

References (15)

1. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of1,612 patients entered into the MRC AML 10 trial. Blood 1998;92:2322-2333. (Pubitemid 28452973)
2. Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 2000;96:4075-4083.
3. Grimwade D, Walker H, Harrison G, et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001;98:1312-1320.
4. Byrd JC, Mrozek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia group B (CALBG 8461). Blood 2002;100:4325-4336. (Pubitemid 35429670)
5. Wattel E, Preudhomme C, Hecquet B, et al. p53 mutations are associated with resistance to chemotherapy and short survival in hematologicmalignancies. Blood 1994;84:3148-3157.
6. Schoch C, Kern W, Kohlmann A, Hiddemann W, Schnittger S, Haferlach T. Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile. Genes Chromosomes Cancer 2005;43:227-238. (Pubitemid 40726868)
7. Schoch C, Haferlach T, Bursch S, et al. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluores-cence in situ hybridization including 24-color FISH. Genes Chromosomes Cancer 2002;35:20-29. (Pubitemid 34847865)
8. Lindvall C, Furge K, Björkholm M, et al. Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes. Haematologica 2004;89: 1072-1081. (Pubitemid 39295478)
9. Haferlach C, Dicker F, Herholz H, Schnittger S, Kern W, Haferlach T. Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype. Leukemia 2008;22:1539-1541.
10. Tlsty TD. Functions of p53 suppress critical consequences of damage and repair in the initiation of cancer. Cancer Cell 2002;2:2-4. (Pubitemid 41043981)
11. Breems DA, Van Putten WL, De GreefGE, et al. Monosomal karyotype in acute myeloid leukemia:a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008;26: 4791-4797.
12. Mrózek K. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype. Semin Oncol 2008;35:365-377.
13. Seifert H, Mohr B, Thiede C, et al., Study Alliance Leukemia (SAL). The prognostic inpact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia. Leukemia 2009;23:656-663.
14. Basara N, Schulze A, Wedding U, et al. Early related or unrelated haematopoietic cell and transplantation results in higher overall survival leukaemia-free survival risk compared with conventional chemotherapy in high-risk acute myeloid-leukaemia patients in first complete remission. Leukemia 2009;23:635-640.
15. Davies SM, Rowe JM, Appelbaum FR Indications for hematopoietic stem cell transplantation in acute leukemia. Biol Blood Marrow Transplant 2008;14:154-164. (Pubitemid 350286853)